XTANT MEDICAL HOLDINGS INC (XTNT) Stock Earnings & Estimates
USA - NYSEARCA:XTNT - US98420P3082 - Common Stock
0.65 USD
+0.01 (+1.56%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 57.969M 4.90% | 91.303M 57.50% | 117.267M 28.44% | 132.55M 13.03% | 120.67M -8.96% | 132.14M 9.51% | |
| EBITDA YoY % growth | -5.463M -116.61% | -6.984M -27.84% | -7.85M -12.40% | 8.16M 203.95% | 12.342M 51.25% | N/A | |
| EBIT YoY % growth | -6.755M -75.27% | -10.158M -50.38% | -12.074M -18.86% | 4.743M 139.28% | 4.284M -9.68% | 7.701M 79.76% | |
| Operating Margin | -11.65% | -11.13% | -10.30% | 3.58% | 3.55% | 5.83% | |
| EPS YoY % growth | N/A | 0.00 | -0.12 -1,729,382,256,910,270,500.00% | -0.02 83.00% | -0.02 25.00% | 0.01 166.67% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 87.25% | -0.01 49.00% | 0.00 | 0.00 -100.00% | 0.00 100.00% | 0.00 100.00% |
| Revenue Q2Q % growth | 33.354M 19.39% | 29.529M -6.30% | 29.427M -10.57% | 30.6M -13.59% | 28.866M -13.46% | 31.773M 7.60% |
| EBITDA Q2Q % growth | 3.468M 594.72% | 2.244M -4.18% | 2.448M 14.55% | 2.754M 200.00% | 3.264M -5.88% | 3.672M 63.64% |
| EBIT Q2Q % growth | 255K 106.75% | -255K 86.45% | 816K -23.24% | 918K 357.14% | 1.173M 360.00% | 1.377M 640.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.02 166.67% | -0.01 | 0.03 | 296.08% |
| Q1 2025 Q2Q % growth | 0.00 100.00% | -0.01 | 0.01 | 100.00% |
| Q4 2024 Q2Q % growth | -0.02 33.33% | -0.02 | 0.00 | -30.72% |
| Q3 2024 Q2Q % growth | -0.04 -157.14% | -0.03 | -0.01 | -56.86% |
| Q2 2024 Q2Q % growth | -0.03 -50.00% | -0.02 | -0.01 | -47.06% |
| Q1 2024 Q2Q % growth | -0.03 -50.00% | -0.02 | -0.01 | -96.08% |
| Q4 2023 Q2Q % growth | -0.03 -50.00% | -0.03 | 0.00 | -17.65% |
| Q3 2023 Q2Q % growth | 0.07 333.33% | -0.02 | 0.09 | 443.14% |
| Q2 2023 Q2Q % growth | -0.02 | -0.02 | 0.00 | 1.96% |
| Q1 2023 Q2Q % growth | -0.02 33.33% | -0.03 | 0.01 | 34.64% |
| Q4 2022 Q2Q % growth | -0.02 33.33% | % | ||
| Q3 2022 Q2Q % growth | -0.03 -50.00% | % | ||
| Q4 2021 Q2Q % growth | -0.03 -200.00% | % | ||
| Q3 2021 Q2Q % growth | -0.02 80.00% | % | ||
| Q1 2021 Q2Q % growth | 0.00 100.00% | % | ||
| Q4 2020 Q2Q % growth | -0.01 91.67% | % | ||
| Q3 2020 Q2Q % growth | -0.10 28.57% | -0.11 | 0.01 | 10.87% |
| Q2 2020 Q2Q % growth | -0.19 -26.67% | -0.11 | -0.08 | -69.34% |
| Q1 2020 Q2Q % growth | -0.19 9.52% | % | ||
| Q4 2019 Q2Q % growth | -0.12 | -0.21 | 0.09 | 43.98% |
| Q3 2019 Q2Q % growth | -0.14 | -0.29 | 0.15 | 50.98% |
| Q1 2019 Q2Q % growth | -0.21 | -0.37 | 0.16 | 42.81% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 35.411M 18.26% | 31.977M | 3.434M | 10.74% |
| Q1 2025 Q2Q % growth | 32.904M 18.05% | 31.824M | 1.08M | 3.39% |
| Q4 2024 Q2Q % growth | 31.513M 12.11% | 32.436M | -923K | -2.85% |
| Q3 2024 Q2Q % growth | 27.937M 11.66% | 29.886M | -1.949M | -6.52% |
| Q2 2024 Q2Q % growth | 29.943M 48.00% | 29.274M | 669K | 2.29% |
| Q1 2024 Q2Q % growth | 27.873M 55.34% | 26.265M | 1.608M | 6.12% |
| Q4 2023 Q2Q % growth | 28.108M 84.07% | 27.081M | 1.027M | 3.79% |
| Q3 2023 Q2Q % growth | 25.019M 73.00% | 19.278M | 5.741M | 29.78% |
| Q2 2023 Q2Q % growth | 20.232M 32.43% | 19.89M | 342K | 1.72% |
| Q1 2023 Q2Q % growth | 17.943M 38.46% | 15.504M | 2.439M | 15.73% |
| Q4 2022 Q2Q % growth | 15.27M 9.31% | % | ||
| Q3 2022 Q2Q % growth | 14.462M 4.97% | % | ||
| Q2 2022 Q2Q % growth | 15.277M 2.02% | % | ||
| Q1 2022 Q2Q % growth | 12.959M 3.32% | % | ||
| Q4 2021 Q2Q % growth | 13.97M -0.32% | % | ||
| Q3 2021 Q2Q % growth | 13.777M -1.71% | % | ||
| Q2 2021 Q2Q % growth | 14.975M 42.23% | % | ||
| Q1 2021 Q2Q % growth | 12.542M -15.13% | % | ||
| Q4 2020 Q2Q % growth | 14.015M -17.38% | % | ||
| Q3 2020 Q2Q % growth | 14.016M -10.85% | 16.356M | -2.34M | -14.31% |
| Q2 2020 Q2Q % growth | 10.529M -31.05% | 12.461M | -1.932M | -15.50% |
| Q1 2020 Q2Q % growth | 14.778M -11.65% | % | ||
| Q4 2019 Q2Q % growth | 16.964M | 17.696M | -732K | -4.14% |
| Q3 2019 Q2Q % growth | 15.721M | 16.378M | -657K | -4.01% |
| Q1 2019 Q2Q % growth | 16.726M | 17.149M | -423K | -2.47% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 42.86% |
| Revenue | 0% | 0% | 0% | 1.25% |